Han Ju
Qingdao, 266021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Inhibitors of the Influenza Virus Polymerase Basic 2 (PB2): Recent Advances and Future Perspectives.
Inhibitors of the Influenza Virus Polymerase Basic 2 (PB2): Recent Advances and Future Perspectives.
Journal: ACS infectious diseases
Published: June 02, 2026
Diagnostic Value of miR-1225-5p in Acute Coronary Syndrome and its Mechanism in ox-LDL Induced Human Coronary Artery Endothelial Cells Injury.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: February 27, 2026
Discovery of Stable and Permeable N-Methylated Cyclic Peptides to Block the Endocytosis of GluA2 AMPAR for Ischemic Stroke Therapy.
Journal: Journal of medicinal chemistry
Published: February 18, 2026
Stapled Peptides with Therapeutic Potential for Ischemic Stroke by Blocking the Endocytosis of GluA2 AMPAR.
Journal: Journal of medicinal chemistry
Published: February 03, 2026
Discovery of novel pyrrolidine-2,5-dione scaffold PICK1 PDZ inhibitors as anti-ischemic stroke agents.
Journal: European journal of medicinal chemistry
Published: September 25, 2025
Development of cell-permeable and plasma-stable peptidomimetic inhibitors against PSD-95/nNOS interaction as potential anti-ischemic stroke agents.
Journal: European journal of medicinal chemistry
Published: May 22, 2025
Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo.
Journal: Antiviral research
Published: June 14, 2024
Development of chalcone-like derivatives and their biological and mechanistic investigations as novel influenza nuclear export inhibitors.
Journal: European journal of medicinal chemistry
Published: August 05, 2023
Identification of the Imidazo[1,2-a]pyrazine Derivative A4 as a Potential Influenza Virus Nucleoprotein Inhibitor.
Journal: ACS pharmacology & translational science
Published: August 03, 2023
Discovery of ligustrazine and chalcone derivatives as novel viral nucleoprotein nuclear export inhibitors against influenza viruses.
Journal: Journal of medical virology
Published: May 22, 2023
Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant.
Journal: Molecules (Basel, Switzerland)
Published: September 06, 2022
Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity.
Journal: Journal of medicinal chemistry
Published: August 08, 2022
Last Updated: 09/26/2026